These Analysts Cut Their Forecasts On Amdocs Following Q4 Results

Benzinga11-13

Amdocs Limited (NASDAQ:DOX) reported better-than-expected earnings for the fourth quarter on Tuesday.

The company posted quarterly earnings of $1.83 per share which beat the analyst consensus estimate of $1.82 per share. The company reported quarterly sales of $1.150 billion which beat the analyst consensus estimate of $1.146 billion.

Amdocs said it sees first-quarter adjusted EPS of $1.73-$1.79 versus market estimates of $1.87. The company sees first-quarter sales of $1.135 billion-$1.175 billion, versus market expectations of $1.153 billion.

“Fiscal 2025 was another important year as we delivered financial results consistent with our expectations while serving our global telecommunications customers with cutting-edge cloud, digital and AI-driven solutions designed to meet their strategic imperatives. Cloud-related activities delivered double-digit growth, reaching over 30% of total revenue, and we achieved significantly better profitability while maintaining our commitment to R&D. The year finished with very strong sales momentum,” said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.

Amdocs shares fell 7.5% to trade at $77.64 on Wednesday.

These analysts made changes to their price targets on Amdocs following earnings announcement.

  • B of A Securities analyst Tal Liani maintained Amdocs with a Buy and lowered the price target from $100 to $97.
  • Stifel analyst Shlomo Rosenbaum maintained the stock with a Buy and cut the price target from $100 to $97.

Considering buying DOX stock? Here’s what analysts think:

Read This Next:

  • Top 2 Consumer Stocks That Are Ticking Portfolio Bombs

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment